2020
United States
University of Delaware; University of Michigan; Georgia Institute of Technology; Yale University
The PRIME Lab at the University of Michigan, led by Dr. Aaron Morris, focuses on the intersection of biomaterials engineering, immunology, and drug delivery. Their work includes studying immunological niches, diagnosing diseases, and developing therapeutics using engineered materials. The lab has received grants and awards for their research and collaborates with other groups. They have a diverse team of researchers working on projects related to autoimmunity and tissue immunology. The lab values inclusivity and aims to create a supportive environment for growth and contribution to the knowledge enterprise. Their research projects involve developing material platforms for monitoring the innate and adaptive immune systems. The lab welcomes collaborations and visitors interested in their work. // My thesis work centers around development of new biomaterials specifically for applications in regenerative medicine and drug delivery. Recent Publications: Morris AH, Mahal R, Udell J, Wu M, Kyriakides TR. Multi-compartment Drug Release System for Dynamic Modulation of Tissue Responses. Advanced Healthcare Materials 2017.Morris AH, Stamer DK, Kyriakides TR. The Host Response to Naturally-Derived Extracellular Matrix Biomaterials. Seminars in Immunology 2017. Morris AH, Chang J, Kyriakides TR. Inadequate Processing of Decellularized Dermal MatrixReduces Cell Viability In Vitro and Increases Apoptosis and Acute Inflammation In Vivo. BioResearch Open Access 2016.Morris AH, Kyriakides TR. Matricellular proteins and biomaterials. Matrix Biol 2014.Schwan J, Kwaczala AT, Ryan TJ, Bartulos O, Ren Y, Sewanan LR, Morris AH, et al. Scientific Reports 2016.Jha R, Wile B, Wu Q, Morris AH, Maher KO, Wagner MB, et al. Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells. Biomaterials 2015;50:176–85.Johnson, CG, Sharma, KV, Levy, EB, Woods, DL, Morris, AH, et al. Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization. Journal of Vascular and Interventional Radiology 2015; 1–12. // Advisor: Dr. Lonnie Shea // Advisor: Dr. Lonnie Shea // University of Delaware; University of Michigan; Georgia Institute of Technology; Yale University // Aaron Morris is a skilled researcher specializing in the development of biomaterials for regenerative medicine and drug delivery applications. His expertise lies in designing multi-compartment drug release systems and studying the host response to extracellular matrix biomaterials. With a focus on matricellular proteins and biomaterial interactions, Aaron has contributed to various publications in reputable journals. Under the guidance of Dr. Lonnie Shea, he has explored innovative approaches in tissue engineering and cell therapy. Aaron's work showcases a deep understanding of biomaterial science and its implications for advancing medical treatments. // My work focuses on using engineered materials and synthetic biology as platforms to: study immunology, diagnose disease, and develop therapeutics. My long-term vision is to develop non-invasive systems for monitoring immunity within tissues with a particular focus on autoimmune disease. As an academic scientist, I strive to contribute new knowledge and technologies, but also maintain a strong focus on education and mentoring of the next generation of scientist and engineers. // Dr. Aaron Morris is a dedicated researcher at the University of Michigan, leading the PRIME Lab in pioneering work at the intersection of biomaterials engineering, immunology, and drug delivery. His expertise lies in developing innovative material platforms for monitoring immune responses within tissues, with a specific focus on autoimmune diseases. Dr. Morris and his diverse team of researchers collaborate on projects related to autoimmunity, tissue immunology, and multi-compartment drug release systems. With a strong emphasis on inclusivity and mentorship, Dr. Morris is committed to advancing medical treatments through his deep understanding of biomaterial science and matricellular proteins. // Immunoengineer // We need an inside-out approach to how we diagnose disease, says immuno-engineer and TED Fellow Aaron Morris. Introducing cutting-edge medical research, he unveils implantable technology that gives real-time, continuous analysis of a patient's health at the molecular level. "We're creating a diagnostic lab inside your body," Morris says -- and it may pave the way to diagnosing and treating disease better and faster than ever before. // Dr. Aaron Morris is a dedicated researcher at the University of Michigan, leading the PRIME Lab in pioneering work at the intersection of biomaterials engineering, immunology, and drug delivery. His expertise lies in developing innovative material platforms for monitoring immune responses within tissues, with a specific focus on autoimmune diseases. Dr. Morris and his diverse team of researchers collaborate on projects related to autoimmunity, tissue immunology, and multi-compartment drug release systems. With a strong emphasis on inclusivity and mentorship, Dr. Morris is committed to advancing medical treatments through his deep understanding of biomaterial science and matricellular proteins. // Immunoengineer // research, regenerative, technology, synthetic biology, data analysis, immunoengineering, education, open access, led, biomaterials, monitoring, data, bioengineering, autoimmunity, disease, stem, regenerative medicine // Michigan|Ann Arbor|United States|USA